Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
about
Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adultsAutonomic dysfunction in essential hypertension: A systematic reviewSympathetic nervous system overactivity and its role in the development of cardiovascular diseaseInfluence of endogenous angiotensin II on control of sympathetic nerve activity in human dehydration.Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.Therapeutic strategies for targeting excessive central sympathetic activation in human hypertensionAntihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.Pathophysiology of resistant hypertension: the role of sympathetic nervous systemSpironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients.Hydralazine is involved in tele-methylhistamine metabolism by inhibiting monoamine oxidase B in pregnancy-associated hypertensive mice.Angiotensin receptor blockers: new considerations in their mechanism of action.Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humansNerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.Central sympathetic overactivity: maladies and mechanisms.Clinical profile of eprosartan: a different angiotensin II receptor blocker.Sympathetic neural mechanisms in human cardiovascular health and disease.Sympathetic neural mechanisms in human blood pressure regulation.The sympathetic nervous system and blood pressure in humans: implications for hypertension.The role of the kidney and the sympathetic nervous system in hypertension.Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?Sympathomodulatory Effects of Antihypertensive Drug Treatment.Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life.Functional sympatholysis is impaired in hypertensive humans.Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat.Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.Effect of angiotensin AT1 receptor blockade on sympathetic responses to handgrip in healthy men.
P2860
Q24186372-A3C8E132-B05D-47F5-94D4-2D32AB76F060Q27025278-AEF2E56E-916D-4FB0-A23D-F3D5C81D81BCQ28279754-AF8C8FDE-C971-425E-BA5C-3728A93DC6C8Q33157898-159C7DE9-5F60-487F-84F1-A18B1F5459B1Q33655956-572D5934-530A-4FE9-9A91-BE3A3C381206Q33805761-4C6675F7-06F7-4C74-B406-4CCC093AA2B1Q34007047-7E6A0A6B-AF6F-4270-A682-BDC1C2AD4AD3Q34557252-400F38F1-7E3E-4CD9-A24B-2EF33C38C5FCQ36106582-D7DA56FD-F8FB-4639-AEB7-1A84930FAA29Q36245027-6009B5CF-2DFD-4C49-B74F-D4A6685FF2CDQ36474742-F6AD21FD-5439-40D2-B160-C0FB81C86E0FQ36792674-86B20567-7351-48E2-933D-AEE48B3111F8Q37038881-FCD4BCC9-8E5E-42CC-9356-381B8F658C30Q37186153-E13DD8A5-FB68-437E-9B6A-679EAB71747CQ37294181-53EAC07D-07C1-4E8E-951C-FC493FDCE484Q37327147-605B2784-5407-4998-BC9D-A1EF5A4946FBQ37835754-D83CF133-CFDC-4876-92F0-6067E6471250Q37898511-05787955-266E-4B6D-8BC8-372928A8AF32Q38194474-47C903AA-F1DC-4F4E-8DC0-8793304C599AQ38484107-A9D9EA9F-A9D2-4A6E-A29C-315AE95EFF99Q38738260-6A374CA5-4670-48EB-9126-B32D11A41A4CQ41664884-F36A3CBD-1664-4A82-94C8-C220A08CC214Q42380125-2230B735-5197-4A46-BED9-CBF1F5E69B44Q43225774-CB360130-02E5-44B2-BEBF-7B3C03564B1DQ45387746-32383B6F-36DC-4480-AA23-84D91B7A5C63Q46039857-78775687-B601-4225-8CE8-119DF8868137Q46767827-654B93D9-E52C-4033-A31E-731A09C75066Q48172296-D26B41F4-2FA1-4F11-B656-9613E710E4F7Q53946487-0F11A9EC-D153-4BAF-93F6-D8795EEF5656
P2860
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effect of angiotensin II recep ...... s with essential hypertension.
@en
Effect of angiotensin II recep ...... s with essential hypertension.
@nl
type
label
Effect of angiotensin II recep ...... s with essential hypertension.
@en
Effect of angiotensin II recep ...... s with essential hypertension.
@nl
prefLabel
Effect of angiotensin II recep ...... s with essential hypertension.
@en
Effect of angiotensin II recep ...... s with essential hypertension.
@nl
P2093
P2860
P1476
Effect of angiotensin II recep ...... s with essential hypertension.
@en
P2093
Duncan J Campbell
Emma Windebank
Murray Esler
P2860
P304
P356
10.1152/AJPHEART.00885.2005
P577
2005-11-11T00:00:00Z